Ginwa Enterprise (Group) Inc.
Ginwa Enterprise (Group) Inc.
Share · CNE000000QQ8 (XSHG)
Overview
No Price
Closing Price XSHG 28.10.2025: 7,57 CNY
28.10.2025 07:00
Current Prices from Ginwa Enterprise (Group) Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
XSHG: SSE
SSE
600080.SS
CNY
28.10.2025 07:00
7,57 CNY
0,02 CNY
+0,26 %
Share Float & Liquidity
Free Float 89,98 %
Shares Float 335,88 M
Shares Outstanding 373,27 M
Company Profile for Ginwa Enterprise (Group) Inc. Share
Ginwa Enterprise (Group) Inc. researches, develops, produces, and sells proprietary Chinese, biological, and chemical medicines in China. It offers orthopedic, immune, pediatric, antibiotic, digestive system, gynecological, cardiovascular, antipyretic, analgesic, antiviral, and other products. The company provides its products in the form of capsules, powders, and tablets. Ginwa Enterprise (Group) Inc. is based in Xi'an, China.
Get up to date insights from finAgent about Ginwa Enterprise (Group) Inc.

Company Data

Name Ginwa Enterprise (Group) Inc.
Company Ginwa Enterprise (Group) Inc.
Website https://www.ginwa.com.cn
Primary Exchange XSHG SSE
ISIN CNE000000QQ8
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Boyue Xing
Market Capitalization 3 Mrd.
Country China
Currency CNY
Employees 0,6 T
Address No. 202, Keji 4th Road, Xi'an
IPO Date 1997-06-12

Ticker Symbols

Name Symbol
SSE 600080.SS
More Shares
Investors who hold Ginwa Enterprise (Group) Inc. also have the following shares in their portfolio:
LEGAL GENL GRP 18/48 FLR
LEGAL GENL GRP 18/48 FLR Bond
TICK TRADING SOFTW. NA ON
TICK TRADING SOFTW. NA ON Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025